ebomi
Colour theme
Sign in
Insider · CIK 0001377832

Strobeck Matthew

CIK 0001377832 Name as filed on the most recent filing

Filed as Strobeck Matthew (26)

70 transaction lines · from 26 filings · filed 2007-06-14 to 2026-02-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

54 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-02-13 P, Open-market purchase QuidelOrtho CorpQDEL 239,586, acquired Open Form 4 filing 0001377832-26-000003
2024-11-05 P, Open-market purchase Biodesix IncBDSX 2 lines 55,916, acquired Open Form 4 filing 0000905148-24-002950
2024-01-23 P, Open-market purchase Accelerate Diagnostics, IncAXDX Not reported Open Form 4 filing 0001104659-24-006678
2023-03-27 P, Open-market purchase Elutia Inc.ELUT 15,870, acquired Open Form 4 filing 0001104659-24-025392
2023-03-27 P, Open-market purchase Aziyo Biologics, Inc.AZYO 15,870, acquired Open Form 4 filing 0001104659-23-037129
2023-03-24 P, Open-market purchase Elutia Inc.ELUT 2 lines 27,078, acquired Open Form 4 filing 0001104659-24-025392
2023-03-24 P, Open-market purchase Aziyo Biologics, Inc.AZYO 2 lines 27,078, acquired Open Form 4 filing 0001104659-23-037129
2023-03-23 P, Open-market purchase Elutia Inc.ELUT 2 lines 164,010, acquired Open Form 4 filing 0001104659-24-025392
2023-03-23 P, Open-market purchase Aziyo Biologics, Inc.AZYO 2 lines 164,010, acquired Open Form 4 filing 0001104659-23-037129
2022-12-08 P, Open-market purchase Aziyo Biologics, Inc.AZYO 2 lines 49,518, acquired Open Form 4 filing 0001104659-23-019991
2022-12-07 P, Open-market purchase Aziyo Biologics, Inc.AZYO 2 lines 157,520, acquired Open Form 4 filing 0001104659-23-019991
2022-12-01 P, Open-market purchase Aziyo Biologics, Inc.AZYO 190,000, acquired Open Form 4 filing 0001104659-23-019991
2022-11-21 P, Open-market purchase Biodesix IncBDSX 6 lines 3,069,996, acquired Open Form 4 filing 0001140361-22-042597
2022-05-11 P, Open-market purchase Aziyo Biologics, Inc.AZYO 1,192, acquired Open Form 4 filing 0001104659-23-019991
2022-04-07 P, Open-market purchase Biodesix IncBDSX 2 lines 1,999,999, acquired Open Form 4 filing 0001567619-22-008353
2021-12-30 P, Open-market purchase Biodesix IncBDSX 2 lines 642,930, acquired Open Form 4 filing 0001567619-22-000277
2020-10-30 P, Open-market purchase Biodesix IncBDSX 1,499,994, acquired Open Form 4 filing 0001209191-20-056750
2020-09-03 P, Open-market purchase Quidel Corp /DE/QDEL 2 lines 62,254, acquired Open Form 4 filing 0001209191-20-049663
2020-09-02 P, Open-market purchase Quidel Corp /DE/QDEL 2 lines 1,216,511, acquired Open Form 4 filing 0001209191-20-049663
2020-03-18 P, Open-market purchase Accelerate Diagnostics, IncAXDX 71,100, acquired Open Form 4 filing 0001628280-20-003862
2017-01-09 P, Open-market purchase Accelerate Diagnostics, IncAXDX 152,000, acquired Open Form 4 filing 0001144204-17-001695
2016-02-09 P, Open-market purchase Accelerate Diagnostics, IncAXDX 230,400, acquired Open Form 4 filing 0001144204-16-080228
2015-12-15 P, Open-market purchase Accelerate Diagnostics, IncAXDX 1,499,995, acquired Open Form 4 filing 0001144204-15-071582
2015-06-19 P, Open-market purchase Metabolix, Inc.MBLX 2 lines 483,624, acquired Open Form 4 filing 0001179110-15-010186
2015-03-19 P, Open-market purchase Accelerate Diagnostics, IncAXDX 44,080, acquired Open Form 4 filing 0001144204-15-017674
2014-08-22 P, Open-market purchase Metabolix, Inc.MBLX Not reported Open Form 4 filing 0001179110-14-013292
2014-08-22 P, Open-market purchase Metabolix, Inc.MBLX Not reported Open Form 4 filing 0001179110-14-013292
2014-08-22 P, Open-market purchase Metabolix, Inc.MBLX Not reported Open Form 4 filing 0001179110-14-013292
2014-08-22 P, Open-market purchase Metabolix, Inc.MBLX Not reported Open Form 4 filing 0001179110-14-013292
2014-08-22 P, Open-market purchase Metabolix, Inc.MBLX Not reported Open Form 4 filing 0001179110-14-013292
2014-08-22 P, Open-market purchase Metabolix, Inc.MBLX Not reported Open Form 4 filing 0001179110-14-013292
2014-08-05 P, Open-market purchase Accelerate Diagnostics, IncAXDX 334,000, acquired Open Form 4 filing 0001144204-14-047200
2014-08-04 P, Open-market purchase Accelerate Diagnostics, IncAXDX 334,000, acquired Open Form 4 filing 0001144204-14-047277

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 41
  • Open-market sale 13
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Strobeck Matthew, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001377832

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.